Article

marketwatch.com on 2020-11-26 04:45

AstraZeneca defends dosing error in COVID-19 trial

A top executive at AstraZeneca PLC pushed back on Wednesday against criticism that the company failed to disclose enough data from a clinical trial of ...

Related news